Evidence map›Paper›PMID 41519991›Full record

ArticleScientific reports2026

Integration of 12-h time-restricted feeding with exercise training potentiates weight loss and attenuates MASLD in diet-induced obese mice.

Guilherme Correia Ferri Antonio, Ana Paula Azevêdo Macêdo, Gabriel Calheiros Antunes, Robson Damasceno de Lima, Thaiane da Silva Rios, Beatriz de Souza Pitoli, Guilherme Domingos Brisque, Larissa Moreira Dias, Adelino Sanchez Ramos da Silva, Dennys Esper Cintra and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Guilherme Correia Ferri AntonioLaboratory of Molecular Biology of Exercise, University of Campinas (UNICAMP), Limeira, São Paulo, Brazil.
Ana Paula Azevêdo MacêdoLaboratory of Molecular Biology of Exercise, University of Campinas (UNICAMP), Limeira, São Paulo, Brazil.
Gabriel Calheiros AntunesLaboratory of Molecular Biology of Exercise, University of Campinas (UNICAMP), Limeira, São Paulo, Brazil.
Robson Damasceno de LimaLaboratory of Molecular Biology of Exercise, University of Campinas (UNICAMP), Limeira, São Paulo, Brazil.
Thaiane da Silva RiosLaboratory of Nutritional Genomics, University of Campinas (UNICAMP), Limeira, São Paulo, Brazil.
Beatriz de Souza PitoliLaboratory of Molecular Biology of Exercise, University of Campinas (UNICAMP), Limeira, São Paulo, Brazil.
Guilherme Domingos BrisqueLaboratory of Molecular Biology of Exercise, University of Campinas (UNICAMP), Limeira, São Paulo, Brazil.
Larissa Moreira DiasLaboratory of Molecular Biology of Exercise, University of Campinas (UNICAMP), Limeira, São Paulo, Brazil.
Adelino Sanchez Ramos da SilvaPostgraduate Program in Rehabilitation and Functional Performance, Ribeirão Preto Medical School, and Postgraduate Program in Physical Education and Sport, School of Physical Education and Sport of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil.
Dennys Esper CintraOCRC - Obesity and Comorbidities Research Center, University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.
Rania A MekaryMassachusetts College of Pharmacy and Health Sciences, Boston, MA, USA.
Eduardo Rochete RopelleLaboratory of Molecular Biology of Exercise, University of Campinas (UNICAMP), Limeira, São Paulo, Brazil.
Amandine ChaixDepartment of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, UT, USA.
José Rodrigo PauliLaboratory of Molecular Biology of Exercise, University of Campinas (UNICAMP), Limeira, São Paulo, Brazil. rodrigopaulifca@gmail.com.

Funding

Ceramides as novel drivers of metabolic dysfunction and colorectal cancerU01CA272529 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Mary Christine Playdon, SCOTT A SUMMERS · 2022 to 2026
$4.7M
Conselho Nacional de Desenvolvimento Científico e Tecnológico 309268/2023-0Fundação de Amparo à Pesquisa do Estado de Minas Gerais 2023/03677-3Fundação de Amparo à Pesquisa do Estado de São Paulo 2024/16630-8NCI NIH HHS U01 CA272529
6 · The paper itself

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent liver disease worldwide, particularly among individuals with overweight and obesity. Non-pharmacological strategies such as time-restricted feeding (TRF) and exercise training can effectively mitigate obesity and metabolic disorders associated with MASLD. However, the specific effects of TRF combined with aerobic training (AT), resistance training (RT), or combined training (CT) on weight loss and MASLD remain unclear. This study investigated the effects of 12 h-TRF and exercise training (AT, RT, and CT), applied alone or in combination with TRF, for 10 weeks in diet-induced obese male Swiss mice. Individually, TRF and all exercise protocols reduced weight gain and adiposity, improved glycemic homeostasis, and decreased hepatic fat accumulation. Combining TRF with exercise resulted in more pronounced improvements, suggesting complementary mechanisms. Among the interventions, TRF + AT was the most effective in reducing body weight, fat mass, and hepatic saturated fatty acid accumulation. TRF + CT induced similar effects but with a less marked reduction in hepatic steatosis. Moreover, TRF + AT downregulated lipogenic and inflammatory genes while upregulating genes related to hepatic fatty acid oxidation. TRF + RT was particularly effective in improving glucose homeostasis and insulin sensitivity. In conclusion, combining TRF with AT, RT, or CT significantly improved metabolic and hepatic parameters compared to TRF or training alone in obese mice. These findings highlight the synergistic potential of TRF and exercise and emphasize their specific outcomes, providing new perspectives for personalized interventions against obesity and MASLD.

Indexed as

Fatty LiverNon-alcoholic Fatty Liver DiseaseObesityPhysical Conditioning, AnimalWeight LossAdiposityAnimalsDiet, High-FatInsulin ResistanceIntermittent FastingLiverMaleMiceMice, Obese

Identifiers

PMID41519991
PMCPMC12830811

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.